| RS1352801514 |
TNXB
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1352808353 |
FH
|
Health Risk |
Conflicting classifications of pathogenicity |
Fumarase deficiency, Hereditary cancer-predisposing syndrome |
| RS1352813413 |
NKX2-5
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Atrial septal defect 7 |
| RS1352826089 |
CFI
|
Health Risk |
Likely pathogenic/Likely pathogenic, low penetrance |
CFI-related disorder, CFI-related disorder |
| RS1352861184 |
FLNC
|
Health Risk |
Conflicting classifications of pathogenicity |
Myofibrillar myopathy 5, Hypertrophic cardiomyopathy 26 |
| RS1352876349 |
MYO15A
|
Health Risk |
Pathogenic |
— |
| RS1352900858 |
DMD
|
Health Risk |
Conflicting classifications of pathogenicity |
Duchenne muscular dystrophy, Cardiovascular phenotype |
| RS1352910925 |
GPHN
|
Health Risk |
Pathogenic |
Sulfite oxidase deficiency due to molybdenum cofactor deficiency type C, Sulfite oxidase deficiency due to molybdenum cofactor deficiency type C |
| RS1352914856 |
COL27A1
|
Health Risk |
Likely pathogenic |
— |
| RS1352922801 |
HMOX1
|
Health Risk |
Pathogenic |
— |
| RS1352923765 |
COL5A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, classic type |
| RS1352926525 |
SIK1
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 30 |
| RS1352931329 |
CYBA
|
Health Risk |
Pathogenic |
Granulomatous disease, chronic |
| RS1352968108 |
SLC37A4
|
Health Risk |
Pathogenic/Likely pathogenic |
Glucose-6-phosphate transport defect, Glucose-6-phosphate transport defect |
| RS1352981584 |
GALNT3
|
Health Risk |
Likely pathogenic |
— |
| RS1352986086 |
SMPD1
|
Health Risk |
Likely pathogenic |
Niemann-Pick disease, type A |
| RS1352999116 |
SLC45A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Oculocutaneous albinism type 4, Oculocutaneous albinism type 4 |
| RS1353010901 |
HOGA1
|
Health Risk |
Likely pathogenic |
Primary hyperoxaluria type 3, Primary hyperoxaluria type 3 |
| RS1353016807 |
TP53
|
Health Risk |
Conflicting classifications of pathogenicity |
Li-Fraumeni syndrome, Hereditary breast ovarian cancer syndrome |
| RS1353022856 |
LRBA
|
Health Risk |
Likely pathogenic |
Combined immunodeficiency due to LRBA deficiency, Combined immunodeficiency due to LRBA deficiency |
| RS1353055740 |
FRAS1
|
Health Risk |
Likely pathogenic |
Fraser syndrome 1, Fraser syndrome 1 |
| RS1353058781 |
NAGLU
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-III-B |
| RS1353062665 |
AGL
|
Health Risk |
Likely pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS1353073416 |
CCDC40
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1353074803 |
PKP2
|
Health Risk |
Pathogenic/Likely pathogenic |
Arrhythmogenic right ventricular dysplasia 9, Arrhythmogenic right ventricular dysplasia 9 |
| RS1353098253 |
BBS1
|
Health Risk |
Pathogenic/Likely pathogenic |
Bardet-Biedl syndrome 1, Bardet-Biedl syndrome |
| RS1353109719 |
ADAMTS18
|
Health Risk |
Pathogenic |
— |
| RS1353156898 |
COL2A1
|
Health Risk |
Conflicting classifications of pathogenicity |
COL2A1-related disorder, COL2A1-related disorder |
| RS1353165210 |
LIG4
|
Health Risk |
Conflicting classifications of pathogenicity |
DNA ligase IV deficiency, DNA ligase IV deficiency |
| RS1353165398 |
MTRR
|
Health Risk |
Pathogenic/Likely pathogenic |
Methylcobalamin deficiency type cblE, Neural tube defects |
| RS1353172878 |
TMEM260
|
Health Risk |
Likely pathogenic |
Structural heart defects and renal anomalies syndrome, Structural heart defects and renal anomalies syndrome |
| RS1353172956 |
WDR19
|
Health Risk |
Pathogenic/Likely pathogenic |
Asphyxiating thoracic dystrophy 5, Senior-Loken syndrome 8 |
| RS1353173742 |
SMAD6
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1353211680 |
CUX2
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 67 |
| RS1353241230 |
KIZ
|
Health Risk |
Pathogenic |
— |
| RS1353267621 |
DNAJB4
|
Health Risk |
Pathogenic |
Congenital myopathy 21 with early respiratory failure, Congenital myopathy 21 with early respiratory failure |
| RS1353278679 |
DPPA2
|
Health Risk |
Likely pathogenic |
Premature ovarian failure, Premature ovarian failure |
| RS1353290865 |
PIEZO1
|
Health Risk |
Conflicting classifications of pathogenicity |
PIEZO1-related disorder, Inborn genetic diseases |
| RS1353328963 |
MSH3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1353334452 |
COL4A4
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1353373400 |
ATP7B
|
Health Risk |
Pathogenic/Likely pathogenic |
Wilson disease, Wilson disease |
| RS1353393888 |
WFS1
|
Health Risk |
Uncertain significance/Uncertain risk allele |
Wolfram syndrome 1, Wolfram syndrome 1 |
| RS1353395919 |
DSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Arrhythmogenic right ventricular dysplasia 11, Familial isolated arrhythmogenic right ventricular dysplasia |
| RS1353402674 |
CUBN
|
Health Risk |
Likely pathogenic |
Imerslund-Grasbeck syndrome, Proteinuria |
| RS1353409115 |
DYRK1A
|
Health Risk |
Conflicting classifications of pathogenicity |
DYRK1A-related intellectual disability syndrome, Inborn genetic diseases |
| RS1353417724 |
ATP1A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Alternating hemiplegia of childhood 2, Dystonia 12 |
| RS1353421249 |
ASPM
|
Health Risk |
Likely pathogenic |
Microcephaly 5, primary |
| RS1353432136 |
VPS13A
|
Health Risk |
Pathogenic |
— |
| RS1353464242 |
WDR81
|
Health Risk |
Likely pathogenic |
Cerebellar ataxia, intellectual disability |
| RS1353480777 |
COL4A5
|
Health Risk |
Likely pathogenic |
Alport syndrome, Alport syndrome |
| RS1353485252 |
NGLY1
|
Health Risk |
Likely pathogenic |
Congenital disorder of deglycosylation, Congenital disorder of deglycosylation |
| RS1353492847 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1353493677 |
SLC4A2
|
Health Risk |
Pathogenic |
Osteopetrosis, autosomal recessive 9 |
| RS1353506638 |
CACNA1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Episodic ataxia type 2, Developmental and epileptic encephalopathy |
| RS1353512742 |
COL4A4
|
Health Risk |
Likely pathogenic |
Autosomal recessive Alport syndrome, Autosomal recessive Alport syndrome |
| RS1353528319 |
TTN
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS1353535488 |
TCTN1
|
Health Risk |
Pathogenic |
Meckel-Gruber syndrome, Joubert syndrome |
| RS1353542088 |
ARSB
|
Health Risk |
Conflicting classifications of pathogenicity |
Mucopolysaccharidosis type 6, Mucopolysaccharidosis type 6 |
| RS1353542774 |
PCCB
|
Health Risk |
Pathogenic |
Propionic acidemia, Inborn genetic diseases |
| RS1353551542 |
RPGRIP1L
|
Health Risk |
Pathogenic |
Meckel-Gruber syndrome, Joubert syndrome |
| RS1353563172 |
PLOD2
|
Health Risk |
Pathogenic/Likely pathogenic |
Osteogenesis imperfecta, Bruck syndrome 2 |
| RS1353587068 |
MFRP
|
Health Risk |
Pathogenic |
Isolated microphthalmia 5, Isolated microphthalmia 5 |
| RS1353598791 |
MYO7A
|
Health Risk |
Pathogenic/Likely pathogenic |
Usher syndrome, Usher syndrome |
| RS1353606328 |
ARHGEF18
|
Health Risk |
Pathogenic |
— |
| RS1353623780 |
GCH1
|
Health Risk |
Conflicting classifications of pathogenicity |
GTP cyclohydrolase I deficiency, Dystonia 5 |
| RS1353636049 |
GREB1L
|
Health Risk |
Conflicting classifications of pathogenicity |
Renal hypodysplasia/aplasia 3, Mayer-Rokitansky-Kuster-Hauser syndrome |
| RS1353660689 |
WDFY3
|
Health Risk |
Likely pathogenic |
Neurodevelopmental delay, Neurodevelopmental delay |
| RS1353661531 |
MLIP
|
Health Risk |
Pathogenic |
Myopathy with myalgia, increased serum creatine kinase |
| RS1353683992 |
RB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinoblastoma, Hereditary cancer-predisposing syndrome |
| RS1353707093 |
SKIC2
|
Health Risk |
Pathogenic |
SKIC2-related disorder, SKIC2-related disorder |
| RS1353710115 |
CACNA1A
|
Health Risk |
Likely pathogenic |
CACNA1A-related disorder, CACNA1A-related disorder |
| RS1353717821 |
TRAPPC11
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type R18, Inborn genetic diseases |
| RS1353723750 |
DNAH5
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1353732061 |
RBM20
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1DD, Cardiovascular phenotype |
| RS1353746682 |
CHD7
|
Health Risk |
Conflicting classifications of pathogenicity |
CHARGE syndrome, Inborn genetic diseases |
| RS1353757275 |
SLC19A3
|
Health Risk |
Pathogenic/Likely pathogenic |
Biotin-responsive basal ganglia disease, Biotin-responsive basal ganglia disease |
| RS1353761128 |
COL11A2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1353761854 |
AXIN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Oligodontia-cancer predisposition syndrome, Hereditary cancer-predisposing syndrome |
| RS1353778985 |
FUCA1
|
Health Risk |
Pathogenic |
Fucosidosis, Fucosidosis |
| RS1353802225 |
CHRNA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant nocturnal frontal lobe epilepsy, Autosomal dominant nocturnal frontal lobe epilepsy |
| RS1353809695 |
RPGRIP1L
|
Health Risk |
Pathogenic |
Joubert syndrome, Meckel-Gruber syndrome |
| RS1353848256 |
GPSM2
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS1353879401 |
SNX10
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive osteopetrosis 8, Autosomal recessive osteopetrosis 8 |
| RS1353889281 |
GRM6
|
Health Risk |
Pathogenic |
— |
| RS1353891039 |
TERT
|
Health Risk |
Conflicting classifications of pathogenicity |
Dyskeratosis congenita, autosomal dominant 2 |
| RS1353930135 |
MED12
|
Health Risk |
Conflicting classifications of pathogenicity |
FG syndrome, FG syndrome |
| RS1353948871 |
RBM20
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1DD, Cardiovascular phenotype |
| RS1353957108 |
NOBOX
|
Health Risk |
Pathogenic |
Genetic non-acquired premature ovarian failure, Genetic non-acquired premature ovarian failure |
| RS1353971489 |
PCCB
|
Health Risk |
Pathogenic |
Propionic acidemia, Propionic acidemia |
| RS1353981722 |
ABAT
|
Health Risk |
Conflicting classifications of pathogenicity |
Gamma-aminobutyric acid transaminase deficiency, Gamma-aminobutyric acid transaminase deficiency |
| RS1353982573 |
SOS1
|
Health Risk |
Conflicting classifications of pathogenicity |
RASopathy, Cardiovascular phenotype |
| RS1353992080 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia complementation group A |
| RS1354004604 |
SLC7A7
|
Health Risk |
Pathogenic |
Lysinuric protein intolerance, Lysinuric protein intolerance |
| RS1354030520 |
RB1
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Retinoblastoma |
| RS1354042829 |
CNGA3
|
Health Risk |
Pathogenic |
Retinal dystrophy, Achromatopsia 2 |
| RS1354044963 |
RYR1
|
Health Risk |
Likely pathogenic |
RYR1-related disorder, Malignant hyperthermia |
| RS1354060089 |
ASAH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Farber lipogranulomatosis, Farber lipogranulomatosis |
| RS1354063885 |
IMPDH1
|
Health Risk |
Likely pathogenic |
— |
| RS1354079241 |
CPS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital hyperammonemia, type I |
| RS1354082523 |
GBA2
|
Health Risk |
Pathogenic |
Spastic paraplegia, Spastic paraplegia |